Waters ROA 2010-2024 | WAT
Current and historical return on assets (ROA) values for Waters (WAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Waters ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.62B | $4.51B | 13.77% |
| 2024-06-30 | $0.60B | $4.45B | 13.18% |
| 2024-03-31 | $0.60B | $4.51B | 13.29% |
| 2023-12-31 | $0.64B | $4.63B | 15.15% |
| 2023-09-30 | $0.65B | $4.50B | 16.73% |
| 2023-06-30 | $0.68B | $4.55B | 19.01% |
| 2023-03-31 | $0.69B | $3.31B | 21.70% |
| 2022-12-31 | $0.71B | $3.28B | 22.78% |
| 2022-09-30 | $0.70B | $3.07B | 22.76% |
| 2022-06-30 | $0.70B | $3.04B | 22.84% |
| 2022-03-31 | $0.70B | $3.04B | 22.79% |
| 2021-12-31 | $0.69B | $3.10B | 22.10% |
| 2021-09-30 | $0.69B | $3.12B | 22.62% |
| 2021-06-30 | $0.66B | $3.10B | 22.31% |
| 2021-03-31 | $0.62B | $3.21B | 21.65% |
| 2020-12-31 | $0.52B | $2.84B | 19.27% |
| 2020-09-30 | $0.51B | $2.68B | 19.15% |
| 2020-06-30 | $0.52B | $2.65B | 19.78% |
| 2020-03-31 | $0.54B | $2.67B | 20.25% |
| 2019-12-31 | $0.59B | $2.56B | 21.16% |
| 2019-09-30 | $0.58B | $2.56B | 18.64% |
| 2019-06-30 | $0.58B | $2.82B | 16.73% |
| 2019-03-31 | $0.59B | $3.25B | 15.58% |
| 2018-12-31 | $0.59B | $3.73B | 14.47% |
| 2018-09-30 | $0.06B | $4.04B | 1.24% |
| 2018-06-30 | $0.05B | $4.16B | 1.07% |
| 2018-03-31 | $0.03B | $4.49B | 0.54% |
| 2017-12-31 | $0.02B | $5.32B | 0.41% |
| 2017-09-30 | $0.55B | $5.16B | 11.16% |
| 2017-06-30 | $0.54B | $5.00B | 11.28% |
| 2017-03-31 | $0.53B | $4.81B | 11.53% |
| 2016-12-31 | $0.52B | $4.66B | 11.54% |
| 2016-09-30 | $0.50B | $4.58B | 11.28% |
| 2016-06-30 | $0.49B | $4.45B | 11.37% |
| 2016-03-31 | $0.47B | $4.37B | 11.13% |
| 2015-12-31 | $0.47B | $4.27B | 11.51% |
| 2015-09-30 | $0.47B | $4.12B | 11.80% |
| 2015-06-30 | $0.47B | $4.03B | 12.00% |
| 2015-03-31 | $0.46B | $3.87B | 12.00% |
| 2014-12-31 | $0.43B | $3.88B | 11.49% |
| 2014-09-30 | $0.42B | $3.75B | 11.47% |
| 2014-06-30 | $0.41B | $3.73B | 11.32% |
| 2014-03-31 | $0.40B | $3.65B | 11.45% |
| 2013-12-31 | $0.45B | $3.58B | 13.33% |
| 2013-09-30 | $0.48B | $3.43B | 14.79% |
| 2013-06-30 | $0.49B | $3.29B | 15.33% |
| 2013-03-31 | $0.49B | $3.21B | 16.12% |
| 2012-12-31 | $0.46B | $3.17B | 15.55% |
| 2012-09-30 | $0.42B | $3.00B | 14.79% |
| 2012-06-30 | $0.43B | $2.88B | 15.33% |
| 2012-03-31 | $0.43B | $2.84B | 15.85% |
| 2011-12-31 | $0.43B | $2.72B | 16.64% |
| 2011-09-30 | $0.42B | $2.64B | 16.90% |
| 2011-06-30 | $0.42B | $2.57B | 17.42% |
| 2011-03-31 | $0.40B | $2.45B | 17.79% |
| 2010-12-31 | $0.38B | $2.33B | 17.92% |
| 2010-09-30 | $0.36B | $2.21B | 17.71% |
| 2010-06-30 | $0.34B | $2.04B | 17.46% |
| 2010-03-31 | $0.33B | $1.98B | 17.21% |
| 2009-12-31 | $0.32B | $1.91B | 17.77% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.998B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |